MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, SION had $20,664K increase in cash & cash equivalents over the period. -$66,674K in free cash flow.

Cash Flow Overview

Change in Cash
$20,664K
Free Cash flow
-$66,674K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Maturities of marketable securit...
    • Proceeds from initial public off...
    • Stock-based compensation expense
    • Others
Negative Cash Flow Breakdown
    • Purchases of marketable securiti...
    • Amortization of discount on mark...
    • Operating lease liability
    • Others

Cash Flow
2025-12-31
Net loss
-75,268
Stock-based compensation expense
12,066
Non-cash operating lease expense
1,962
Amortization of discount on marketable securities
3,052
Non-cash expense related to ipr&d acquisition
0
Depreciation expense
647
Prepaid expenses and other current assets
2,082
Accounts payable
-417
Accrued expenses and other current liabilities
1,975
Operating lease liability
-2,128
Other assets
0
Net cash used in operating activities
-66,297
Purchases of property and equipment
377
Purchases of marketable securities
325,025
Maturities of marketable securities
206,653
Net cash used in investing activities
-118,749
Proceeds from initial public offering, net of underwriter discounts, commissions and offering costs paid during the period
202,071
Proceeds from issuance of series c convertible preferred stock, net of issuance costs
0
Payment of deferred offering costs
0
Exercise of common stock options
3,639
Net cash provided by financing activities
205,710
Net increase (decrease) in cash, cash equivalents and restricted cash
20,664
Cash, cash equivalents and restricted cash at beginning of period
38,750
Cash, cash equivalents and restricted cash at end of period
59,414
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from initialpublic offering, net of...$202,071K Exercise of common stockoptions$3,639K Net cash provided byfinancing activities$205,710K Net increase(decrease) in cash, cash...$20,664K Canceled cashflow$185,046K Maturities of marketablesecurities$206,653K Stock-based compensationexpense$12,066K Accrued expenses andother current...$1,975K Non-cash operating leaseexpense$1,962K Depreciation expense$647K Net cash used ininvesting activities-$118,749K Net cash used inoperating activities-$66,297K Canceled cashflow$206,653K Canceled cashflow$16,650K Purchases of marketablesecurities$325,025K Net loss-$75,268K Purchases of property andequipment$377K Amortization of discount onmarketable securities$3,052K Operating lease liability-$2,128K Prepaid expenses andother current assets$2,082K Accounts payable-$417K

Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics, Inc. (SION)